New blood test could spot lung cancer mutations better than current methods
NCT ID NCT06595498
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 29 times
Summary
This study evaluates a new, highly sensitive blood test (Plasma-SeqSensei™) that looks for EGFR gene mutations in lung cancer patients. Researchers will compare it to a standard test to see if it finds more mutations. About 130 adults with advanced non-small cell lung cancer will provide a blood sample. The study poses no risk to participants and aims to improve how doctors detect these mutations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARCINOMA, NON-SMALL CELL LUNG CANCER (NSCLC) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Istituto Oncologico Veneto
Padova, 35128, Italy
Conditions
Explore the condition pages connected to this study.